In a remarkable showcase of innovation, three Harvard scientists have been awarded the prestigious Breakthrough Prizes, often dubbed the "Oscars of Science." This year's honors spotlight significant advancements in fields like gene editing, multiple sclerosis research, and obesity treatments, underscoring Harvard's pivotal role in healthcare innovations.Alberto Ascherio, Joel Habener, and David Liu are recognized for their transformative contributions in understanding Epstein-Barr virus's link to multiple sclerosis, the groundbreaking GLP-1 hormone for diabetes and obesity management, and the development of pioneering gene editing technologies.